Bliss GVS Phrma

BSE : 506197 | NSE : BLISSGVS

Industry : Pharma Formulations | ISIN : INE416D01022 | FreeFloat : 40.00% | FnO : No | LotSize : N/A


Intellectual Capital (IC)341.92
Net Worth (NW)734.07
Intrinsic Worth (IW)1,075.99
Market Cap (MC)1,554.42
Economic Value Added-4.19
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)31.78%
IC Gross Margin (EBITDA/IC)39.25%
IC Net Margin (NPT/IC)32.08%
Knowledge Turnover (Sales/IC)2.22
Market to Intrinsic Value (MC/IW)1.44

As OfIntrinsic ValueMarket Price
31 Dec 2019Rs. 104.32Rs. 150.70
29 May 2020 - Rs. 93.70
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : NoSell10 DMA : Rs. 93.86SellStrong Sell
KB > 50% : No50 DMA : Rs. 97.81
0 < M2IV < 1 : NoVol-Price trend : Falling

Question 3 - Is this stock undervalued?


Question 2 - Does this business have significant knowledge assets?


Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.

Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Mar-17
C
258.30
264.62
67.03
65.91
64.36
46.38
36.87
Jun-17
C
225.21
228.71
64.09
59.00
56.02
36.90
21.19
Sep-17
C
226.29
241.45
47.45
42.59
51.60
39.50
33.99
Dec-17
C
195.89
198.23
48.06
41.50
39.12
25.98
25.98
Mar-18
C
167.26
172.80
37.53
32.66
-1.44
-13.72
-13.72
Jun-18
C
205.33
219.20
40.64
38.43
51.04
38.98
38.32
Sep-18
C
228.43
253.30
41.53
39.19
62.80
41.67
41.46
Dec-18
C
220.43
216.53
39.64
37.44
36.48
27.23
24.13
Mar-19
C
244.05
246.84
34.73
32.52
31.60
18.79
18.88
Jun-19
C
211.53
213.64
51.07
48.30
47.41
33.37
34.06
Sep-19
C
210.12
223.02
38.36
34.87
33.81
30.86
34.05
Dec-19
C
147.85
153.37
38.46
35.49
34.41
25.45
22.88
* C - Consolidated, S - Standalone